10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
GILEAD SCIENCES, INC. | |||
Ticker: GILD Fiscal Year: 2015 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 24, 2016) | |||
(In Millions) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
Revenues | |||
Product sales | $ 32,151 | 24,474 | 10,804 |
Royalty, contract and other revenues | 488 | 416 | 398 |
Total revenues | 32,639 | 24,890 | 11,202 |
Costs and Expenses | |||
Cost of goods sold | 4,006 | 3,788 | 2,859 |
Research and development expenses | 3,014 | 2,854 | 2,120 |
Selling, general and administrative expenses | 3,426 | 2,983 | 1,699 |
Total costs and expenses | 10,446 | 9,625 | 6,678 |
Income from operations | 22,193 | 15,265 | 4,524 |
Interest expense | (688) | (412) | (307) |
Other income (expense), net | 154 | 3 | (9) |
Income before provision for income taxes | 21,659 | 14,856 | 4,208 |
Provision for income taxes | 3,553 | 2,797 | 1,151 |
Net income | 18,106 | 12,059 | 3,057 |
Net loss attributable to noncontrolling interest | (2) | (42) | (18) |
Net income attributable to Gilead | 18,108 | 12,101 | 3,075 |
Net income per share attributable to Gilead common stockholders - basic (in US$ per share) | 12.37 | 7.95 | 2.01 |
Shares used in per share calculation - basic | 1,464 | 1,522 | 1,529 |
Net income per share attributable to Gilead common stockholders - diluted (in US$ per share) | 11.91 | 7.35 | 1.81 |
Shares used in per share calculation - diluted | 1,521 | 1,647 | 1,695 |
Cash dividends declared per share (in US$ per share) | 1.29 | 0.00 | 0.00 |
External Links | |
GILEAD SCIENCES, INC. (GILD) Fiscal Year 2015 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |